| ¿µ¹® | nephritis(interstitial) | ÇÑ±Û | ÄáÆÏ¿°, ½ÅÀå¿°(°£Áú¼º) |
|---|---|---|---|
| ¼³¸í | ÄáÆÏ»çÀÌÁú(renal interstitium: ÄáÆÏÀÇ ¼¼´¢°ü »çÀÌÀÇ °áÇÕÁ¶Á÷)ÀÇ ¿°Áõ. ±Þ¼ºÀ¸·Î ÀϾ´Â °£ÁúÄáÆÏ¿°Àº ´ë°³ ¸¹Àº ¾àÀ» º¹¿ëÇÑ ÈÄ¿¡ ¹ß»ýÇÏ´Â µ¥, ¿, ÇǺÎÀÇ º¯»ö, Ç÷¾×³»ÀÇ È£»ê±¸Áõ ±×¸®°í ¼Òº¯ÀÇ °¨¼Ò¿Í ÄáÆÏ±â´ÉÀÇ °¨¼Ò¸¦ Ư¡À¸·Î ÇÑ´Ù. Ä¡·á´Â º¹¿ëÁßÀÎ ¾àÀ» ²÷°í, ºÎ½Å°ÑÁúÈ£¸£¸óÁ¦¸¦ Åõ¿©ÇÑ´Ù. ÄáÆÏÀº °¢Á¾ ³ëÆó¹°, ÀüÇØÁú, ¼öºÐ µîÀ» Æ÷ÇÔÇÑ ¿ä¸¦ »ý»êÇÏ¿© ¹èÃâÇÏ´Â µ¿½Ã¿¡ ¼ö¼ÒÀÌ¿Â, ³ªÆ®·ý, Ä®·ý, Àλê À̿ ³óµµ µîÀ» Á¶ÀýÇÏ¸ç ³»ºÐºñ¿Í ¿ÜºÐºñ ±â´É¿¡ °ü¿©Çϱ⵵ ÇÑ´Ù. |
||
| MPGN | Mesangial(Membrano-) Proliferative Glomerulo-Nephritis |
|---|---|
| DMH | diffuse mesangial hypercellularity |
| DMP | diffuse mesangial proliferation; dimercaprol; dimethylphthalate |
| DMS | delayed match-to-sample; delayed microembolism syndrome; demarcation membrane system; department of ... |
| MesPGN | mesangial proliferative glomerulonephritis |
| DMS | Diffuse mesangial sclerosis |
|---|---|
| HMC | Human mesangial cell |
| MC | Mesangial cell |
| MesPGN | Mesangial proliferative glomerulonephritis |
| GMC | glomerular mesangial cell |
| mesangial nephritis | Glomerulonephritis with an increase in glomerular mesangial cells or matrix, or mesangial deposits. (05 Mar 2000) |
|---|
| mesangial | Referring to the mesangium. (05 Mar 2000) |
|---|---|
| mesangial cell | <pathology> Cells found within the glomerular lobules of mammalian kidney, where they serve as structural supports, may regulate blood flow, are phagocytic and may act as accessory cells, presenting antigen in immune responses. (18 Nov 1997) |
| mesangial proliferative glomerulonephritis | <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome. Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine. Acronym: MPGN (05 Jan 1998) |
| diffuse mesangial proliferation | <nephrology, pathology> Inflammation of the kidney glomerulus (blood filtering portion of the kidney) due to the abnormal deposition of IgM antibody in the mesangium layer of the glomerular capillary. A form of glomerulonephritis that appears to be caused by an abnormal immune response. This disorder generally manifests as nephrotic syndrome. Symptoms include swelling, dark urine, weight gain, hypertension, anorexia and bloody urine. Acronym: MPGN (05 Jan 1998) |
| acute interstitial nephritis | <nephrology> A relatively uncommon condition which is characterised by inflammation of the renal tubules, glomeruli and surrounding tissue. Interstitial nephritis is usually be temporary and often associated with the use of a particular medication. Chronic and progressive forms do exist. Drugs that have been associated with interstitial nephritis include penicillins, ampicillin, sulpha drugs, non-steroidal anti-inflammatory agents, furosemide and thiazide diuretics. May result in mild kidney dysfunction or acute renal failure. Treatment may be with corticosteroids. Incidence: 1 in 25,000. (29 Dec 1997) |
| acute nephritis | <nephrology> A disease of the kidneys that results in inflammation of the glomerulus (the portion of the kidney that filters the blood). Conditions which may cause glomerulonephritis include post-streptococcal disease (strep throat), lupus, syphilis, bacterial endocarditis, membranoproliferative glomerulonephritis, sepsis, vasculitis, Goodpasture's syndrome, typhoid fever, Henoch-Schonlein purpura, hepatitis or a viral infection (for example mumps, measles, mononucleosis). (27 Sep 1997) |
| analgesic nephritis | Chronic interstitial nephritis with renal papillary necrosis, occurring in patients with a long history of excessive consumption of analgesics, especially those containing phenacetin. Synonym: analgesic nephropathy. (05 Mar 2000) |
| anti-basement membrane nephritis | Glomerulonephritis produced by autologous or heterologous antibodies to the glomerular capillary basement membranes, the latter known as anti-kidney serum nephritis. (05 Mar 2000) |
| anti-kidney serum nephritis | Experimental glomerulonephritis produced by injection of antiserum to kidney. (05 Mar 2000) |
| Masugi's nephritis | Glomerulonephritis produced by injecting into rats a rabbit antiserum prepared against rat kidney tissue suspensions. (05 Mar 2000) |
| glomerular nephritis | <nephrology> A variety of nephritis characterised by inflammation of the capillary loops in the glomeruli of the kidney. It occurs in acute, subacute and chronic forms and may be secondary to haemolytic streptococcal infection. Evidence also supports possible immune or autoimmune mechanisms. (18 Nov 1997) |
| chronic nephritis | Glomerulonephritis that presents with persisting proteinuria, chronic renal failure, and hypertension, of insidious onset or as a late sequel of acute glomerulonephritis; the kidneys are symmetrically contracted and granular, with scarring and loss of glomeruli and the presence of tubular atrophy and interstitial fibrosis. Synonym: chronic nephritis. (05 Mar 2000) |
| haemorrhagic nephritis | Acute glomerulonephritis accompanied by haematuria. (05 Mar 2000) |
| salt-losing nephritis | A rare disorder resulting from renal tubular damage of a variety of aetiologies; mimics adrenocortical insufficiency in that abnormal renal loss of sodium chloride occurs, accompanied by hyponatraemia, azotemia, acidosis, dehydration, and vascular collapse. Synonym: salt-losing syndrome, Thorn's syndrome. (05 Mar 2000) |
| hereditary nephritis | <pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon. Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision. Inheritance: sex-linked autosomal dominant. Incidence: 1 in 50,000. (27 Sep 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|